European Agency for the Evaluation of Medicinal Products: fees payable

1994/0220(CNS)
The modified proposal incorporates Parliament's amendment which provides for estimates concerning revenues obtained from fees collected for the following financial year to be included in the annual estimate adopted by the Agency's Management Board under the provision of Article 57 (5) of Regulation No 2309/93. In addition, the proposal partly incorporates the amendment which provides for any Agency budget surplus to be considered under the Community budget, by proposing that a clause providing for these surplus amounts to be deducted from the Community contribution be included in the system. However, the Commission rejected those amendments which used the procedure under Article 189B of the Treaty for introducing any modifications to the regulation. �